Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "inositol signaling pathway" does not refer to one specific molecular entity but rather describes an extensive cellular communication system involving numerous enzymes—including kinases like phosphoinosite 3‑kinase—and second messengers like IP₃ that regulate diverse processes such as metabolism, secretion, proliferation/apoptosis balance, immune responses and more through both primary signal generation and modulatory mechanisms.[1][2] Dysregulation at different points along this axis contributes significantly to diseases ranging from cancer through neurodegeneration.[1] Therapeutic interventions focus on individual proteins within these cascades rather than on the entire system collectively.
Varies by node targeted; examples include: Inhibition of kinase activity leading to reduced cell proliferation/survival signals. Modulation of calcium release from intracellular stores via IP₃ receptors. For example, "LY294002…inhibited tumor growth and promoted apoptosis" by inhibiting PI3K activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol signaling pathway.